Peptide Nanocarrier Targets Macrophages to Kill Hidden MRSA Bacteria Inside Cells | Research

The takeaway

An amphiphilic peptide nanocarrier modified with tuftsin targets macrophages and eradicates intracellular MRSA infections that conventional antibiotics cannot reach.

Intracellular MRSA killed
Tuftsin-targeted nanocarrier delivers drugs inside macrophages where bacteria hide

What the researchers found

RFP@TVYV amphiphilic peptide nanocarrier achieves macrophage-targeted delivery and intracellular MRSA eradication through sequential targeting using tuftsin modification.

Why it matters

Intracellular MRSA infections cause treatment failures and chronic infections. Delivering antimicrobials directly inside the immune cells where bacteria hide could solve one of infectious disease's toughest challenges.

How the study worked

Peptide nanocarrier design with tuftsin modification; macrophage uptake studies; intracellular MRSA killing assays; in vitro and in vivo infection models.

What this study cannot tell us

Preclinical study; macrophage-targeted delivery may vary between tissue compartments; manufacturing scalability of peptide nanocarriers; potential immunogenicity.

How to read the evidence

Preclinical study with in vitro and in vivo models — strong proof of concept for intracellular drug delivery.

When this study was published

Published in 2026, advancing peptide-based solutions for intracellular antibiotic-resistant infections.

The bigger picture

This addresses the Achilles heel of antibiotic therapy — bacteria hiding inside human cells. Peptide-based Trojan horse delivery systems could revolutionize treatment of persistent intracellular infections.

Questions still open

Could this system be adapted for other intracellular pathogens like tuberculosis?
Does the tuftsin-modified carrier affect macrophage immune function beyond drug delivery?

Common questions

Why can't regular antibiotics kill MRSA hiding in immune cells?

Most antibiotics can't efficiently cross cell membranes to reach bacteria hiding inside macrophages. Even when they do, concentrations inside cells are often too low to kill the bacteria, allowing persistent infections.

How does the tuftsin-modified carrier work?

Tuftsin is a natural peptide that macrophages recognize and eagerly engulf. By attaching tuftsin to drug-carrying nanoparticles, researchers trick macrophages into swallowing the medicine — delivering it right where the hidden bacteria are.

Read the original research

Macrophage-targeted amphiphilic peptide nanocarrier for intracellular MRSA infection therapy.

Colloids and surfaces. B, Biointerfaces, 257, 115151

View on PubMed ↗Publisher’s paper ↗

Citation

Chen, Zaipeng; Wu, Yuling; Nie, Zhiqiang; Mao, Tengfei; Tao, Junjun; Tang, Changming; Ruan, Huajun; Lang, Xin; Zhou, Wei; Lu, Jiaju; Li, Xigong. (2026). Macrophage-targeted amphiphilic peptide nanocarrier for intracellular MRSA infection therapy.. Colloids and surfaces. B, Biointerfaces, 257, 115151. https://doi.org/10.1016/j.colsurfb.2025.115151